Health Bulletin 30/September/2023 Roshni Dhar30 Sept 2023 4:22 PM ISTHere are the top health stories for the day:Names of medical colleges not paying stipend to medicos should be made publicStating that the names of the...
Provide in-vivo data, global data: CDSCO Panel Tells Glenmark on Pulmonary FDC in Inhalation Suspension Dr. Divya Colin28 Sept 2023 6:00 PM ISTNew Delhi: In reaction to the request for a waiver of bioequivalence (BE) and Phase III clinical trials for the inhalation suspension of the pulmonary...
Nefecon therapy arrests estimated glomerular filtration rate decline and proteinuria in IgA Nephropathy Jacinthlyn Sylvia22 Aug 2023 8:00 PM ISTA new study published in The Lancet suggested that 9-month Nefecon treatment resulted in a clinically significant decrease in eGFR decline and a...
Both components of albuterol-budesonide combo contribute to lung function efficacy in mild-to-moderate asthma Aditi8 July 2023 9:00 AM ISTA study published in CHEST Journal has concluded that both Albuterol and budesonide contribute to the albuterol-budesonide combination's lung function...
Glenmark Gets CDSCO panel nod for Phase IV CT of COPD drug Dr. Divya Colin22 April 2023 5:45 PM ISTNew Delhi: Pharmaceutical major, Glenmark has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Oral fluvoxamine and inhaled budesonide combo significantly Cuts Severe Disease in COVID-19 Dr. Kamal Kant Kohli21 April 2023 11:00 AM ISTResearchers have found in a randomized controlled trial that treatment with oral antidepressant fluvoxamine plus inhaled budesonide among high-risk...
Is Budesonide effective as first-line therapy in autoimmune hepatitis? Jacinthlyn Sylvia12 April 2023 11:15 AM ISTIn a new study, Álvaro Díaz-González and team found that budesonide is rarely used as a first-line therapy and is often only given to individuals who...
Cipla gets CDSCO Panel nod to manufacture, market COPD drug combination Aerosol for inhalation Susmita Roy23 Nov 2022 6:00 PM ISTNew Delhi: Granting the phase III clinical trial study waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca PT027 recommended by FDA advisory committee as new rescue treatment for asthma Ruchika Sharma9 Nov 2022 1:30 PM ISTAsthma is a chronic, inflammatory, variable respiratory disease that affects as many as 339 million people worldwide, including over 25 million in the...
Zydus Healthcare gets CDSCO panel nod to manufacture, market Indacaterol, Budesonide Inhaler Susmita Roy4 Oct 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Zydus Healthcare has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Oral budesonide, an ideal option for drug treatment of eosinophilic esophagitis: Study Dr. Hiral patel1 Aug 2022 10:00 AM ISTChina: A new study, meta-updates the previous RCT results and confirms that oral budesonide is clinically efficient and safe for long-term use, in the...
Albuterol and budesonide combo reduces risk of severe asthma exacerbations: NEJM Dr. Kamal Kant Kohli17 May 2022 8:00 PM ISTA global study of asthma patients by Rutgers and an international team of researchers found a combination of two drugs dramatically reduces the...
